(FXH) First Trust Health Care - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US33734X1431 • Health

FXH: Healthcare, Pharmaceuticals, Biotechnology, Medical, Devices

The First Trust Health Care AlphaDEX Fund, listed on the NYSE ARCA under the ticker symbol FXH, is designed to provide investors with a unique approach to tapping into the health care sector. By investing at least 90% of its net assets in the securities that comprise its underlying index, the fund aims to deliver a portfolio that closely tracks the performance of this specific segment of the market. The index itself is a modified equal-dollar weighted index, which means that the securities within it are selected and weighted in a way that seeks to optimize their potential for generating alpha, or returns that exceed those of a benchmark index.

The AlphaDEX selection methodology is a key component of this fund's strategy, as it uses a rules-based approach to identify and select stocks from the Russell 1000 Index that are likely to outperform their peers in the health care sector. This methodology takes into account a range of fundamental and quantitative factors, including price momentum, revenue growth, and other metrics that can help to identify companies with strong growth potential. By focusing on the health care sector, the fund provides investors with a way to target a specific area of the market that is known for its potential for long-term growth and innovation.

From a structural perspective, the First Trust Health Care AlphaDEX Fund is an exchange-traded fund (ETF) that is domiciled in the United States and has an International Securities Identification Number (ISIN) of US33734X1431. As an ETF, it offers investors the benefits of transparency, liquidity, and flexibility, as its holdings are disclosed daily and it can be traded throughout the day on an exchange. The fund's website, which can be found at http://www.ftportfolios.com/, provides additional information on its investment objectives, strategies, and performance, as well as other details that may be of interest to potential investors.

In terms of its categorization, the First Trust Health Care AlphaDEX Fund falls under the health care category of ETFs, which means that it is designed to provide investors with a way to gain exposure to the health care sector in a single investment. This can be attractive to investors who are looking to diversify their portfolios and tap into the potential growth opportunities that exist within this sector, which includes companies involved in pharmaceuticals, biotechnology, medical devices, and other related areas. By using a rules-based approach to select its holdings, the fund seeks to provide a disciplined and systematic way to invest in the health care sector, which can help to reduce the risks associated with individual stock selection.

Additional Sources for FXH ETF

FXH ETF Overview

Market Cap in USD 1,066m
Category Health
TER 0.62%
IPO / Inception 2007-05-08

FXH ETF Ratings

Growth 5y 26.0%
Fundamental -
Dividend 32.4%
Rel. Strength Industry -78.7
Analysts -
Fair Price Momentum 100.21 USD
Fair Price DCF -

FXH Dividends

Dividend Yield 12m 0.39%
Yield on Cost 5y 0.51%
Annual Growth 5y 24.75%
Payout Consistency 37.7%

FXH Growth Ratios

Growth Correlation 3m -43%
Growth Correlation 12m 50%
Growth Correlation 5y 17.6%
CAGR 5y 5.44%
CAGR/Mean DD 5y 0.46
Sharpe Ratio 12m 0.19
Alpha -17.56
Beta 0.87
Volatility 13.93%
Current Volume 46.3k
Average Volume 20d 55.2k
What is the price of FXH stocks?
As of January 23, 2025, the stock is trading at USD 109.31 with a total of 46,300 shares traded.
Over the past week, the price has changed by +1.77%, over one month by +3.73%, over three months by +0.24% and over the past year by +5.75%.
Is First Trust Health Care a good stock to buy?
Neither. Based on ValueRay Analyses, First Trust Health Care is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 26.02 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXH as of January 2025 is 100.21. This means that FXH is currently overvalued and has a potential downside of -8.32%.
Is FXH a buy, sell or hold?
First Trust Health Care has no consensus analysts rating.
What are the forecast for FXH stock price target?
According to ValueRays Forecast Model, FXH First Trust Health Care will be worth about 111 in January 2026. The stock is currently trading at 109.31. This means that the stock has a potential upside of +1.5%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 111 1.5%